{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T16:32:38Z","timestamp":1722011558354},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068235","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T21:14:09Z","timestamp":1373404449000},"page":"e68235","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Model-Based Simulation and Prediction of an Antiviral Strategy against Influenza A Infection"],"prefix":"10.1371","volume":"8","author":[{"given":"Kye-Yeon","family":"Hur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Yeon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/516358","article-title":"Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults","volume":"26","author":"JA Englund","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/v2081766","article-title":"Antiviral strategies for pandemic and seasonal influenza","volume":"2","author":"M Hedlund","year":"2010","journal-title":"Viruses"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"NJ Dharan","year":"2009","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3201\/eid1710.110117","article-title":"Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009\u20132010","volume":"17","author":"L Calatayud","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2011.07.004","article-title":"Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009\u20132010","volume":"92","author":"A Meijer","year":"2011","journal-title":"Antiviral Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/infdis\/jis337","article-title":"Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia","volume":"206","author":"AC Hurt","year":"2012","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jmv.23482","article-title":"Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009\u20132011","volume":"85","author":"JR Yang","year":"2013","journal-title":"J Med Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"20266","DOI":"10.2807\/ese.17.36.20266-en","article-title":"Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012","volume":"17","author":"A Meijer","year":"2012","journal-title":"Euro Surveill"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1124\/dmd.107.017699","article-title":"Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein","volume":"36","author":"K Morimoto","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Chairat K, Tarning J, White NJ, Lindegardh N (2012) Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors. J Clin Pharmacol.","DOI":"10.1177\/0091270012440280"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/591851","article-title":"Developing new antiviral agents for influenza treatment: what does the future hold?","volume":"48","author":"F Hayden","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/157489110790112527","article-title":"Influenza antiviral therapeutics","volume":"5","author":"AL Mayburd","year":"2010","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nchembio.645","article-title":"Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor","volume":"7","author":"MA Mata","year":"2011","journal-title":"Nat Chem Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1098\/rstb.2001.0999","article-title":"The evolution of human influenza viruses","volume":"356","author":"AJ Hay","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"RA148","DOI":"10.12659\/MSM.881801","article-title":"Influenza virus and cell signaling pathways","volume":"17","author":"P Gaur","year":"2011","journal-title":"Med Sci Monit"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"JJ Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biochi.2007.04.015","article-title":"Interferon-induced Mx proteins in antiviral host defense","volume":"89","author":"O Haller","year":"2007","journal-title":"Biochimie"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jir.2010.0120","article-title":"New insights into the role of RNase L in innate immunity","volume":"31","author":"A Chakrabarti","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/MCB.6.3.801","article-title":"Activation of the human beta-interferon gene requires an interferon-inducible factor","volume":"6","author":"T Enoch","year":"1986","journal-title":"Mol Cell Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2008.05.052","article-title":"Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression","volume":"134","author":"E Apostolou","year":"2008","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1097-2765(05)00081-X","article-title":"Gene repression by coactivator repulsion","volume":"6","author":"K Senger","year":"2000","journal-title":"Mol Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1093\/nar\/gkm557","article-title":"Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells","volume":"35","author":"J Hu","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1001249","DOI":"10.1371\/journal.pbio.1001249","article-title":"Stochastic expression of the interferon-beta gene","volume":"10","author":"M Zhao","year":"2012","journal-title":"PLoS Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4049\/jimmunol.1202326","article-title":"Biphasic RLR-IFN-beta Response Controls the Balance between Antiviral Immunity and Cell Damage","volume":"190","author":"SY Hwang","year":"2013","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/JVI.01722-10","article-title":"Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling","volume":"85","author":"H Mitchell","year":"2011","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bpj.2009.10.049","article-title":"Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells","volume":"98","author":"L Qiao","year":"2010","journal-title":"Biophys J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/wsbm.129","article-title":"Influenza A virus infection kinetics: quantitative data and models","volume":"3","author":"AM Smith","year":"2011","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2458-11-S1-S7","article-title":"A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead","volume":"11","author":"CA Beauchemin","year":"2011","journal-title":"BMC Public Health"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/bit.20363","article-title":"Mathematical model of influenza A virus production in large-scale microcarrier culture","volume":"90","author":"L Mohler","year":"2005","journal-title":"Biotechnol Bioeng"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.2229","article-title":"Intrinsic antiviral immunity","volume":"13","author":"N Yan","year":"2012","journal-title":"Nat Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3201\/eid1201.051186","article-title":"Antiviral response in pandemic influenza viruses","volume":"12","author":"A Garcia-Sastre","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2009.02.027","article-title":"Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling","volume":"27","author":"J Schulze-Horsel","year":"2009","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"A Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"LV Gubareva","year":"2000","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jmv.20951","article-title":"Neuraminidase inhibitor resistance in influenza viruses","volume":"79","author":"PA Reece","year":"2007","journal-title":"J Med Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2012.02.076","article-title":"A review of influenza haemagglutinin receptor binding as it relates to pandemic properties","volume":"30","author":"S Wilks","year":"2012","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cell.2009.01.029","article-title":"The influenza virus enigma","volume":"136","author":"R Salomon","year":"2009","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1016\/j.vaccine.2006.05.023","article-title":"Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media","volume":"24","author":"Y Genzel","year":"2006","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Y Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874467210902010032","article-title":"Antiviral strategies: the present and beyond","volume":"2","author":"JD Burke","year":"2009","journal-title":"Curr Mol Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/AAC.00476-09","article-title":"Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro","volume":"53","author":"JT Nguyen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1358\/dof.2010.035.05.1487081","article-title":"Antiviral Compounds in the Pipeline to Tackle H1n1 Influenza Infection","volume":"35","author":"JH Beigel","year":"2010","journal-title":"Drugs Future"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/AAC.48.12.4855-4863.2004","article-title":"Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells","volume":"48","author":"EA Govorkova","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/AAC.01012-08","article-title":"Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice","volume":"53","author":"DF Smee","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/AAC.01579-07","article-title":"Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice","volume":"52","author":"NA Ilyushina","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/nar\/gkr1098","article-title":"5\u2032-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity","volume":"40","author":"SY Hwang","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1128\/AAC.39.11.2574","article-title":"Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice","volume":"39","author":"JP Wong","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/JVI.76.10.4901-4911.2002","article-title":"Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus","volume":"76","author":"E Lee","year":"2002","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/viro.2000.0546","article-title":"Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice","volume":"276","author":"KA Bernard","year":"2000","journal-title":"Virology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7883\/yoken.JJID.2004.236","article-title":"Defense mechanisms against influenza virus infection in the respiratory tract mucosa","volume":"57","author":"S Tamura","year":"2004","journal-title":"Jpn J Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T05:46:05Z","timestamp":1715665565000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068235"}},"subtitle":[],"editor":[{"given":"Jodie","family":"McVernon","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068235","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}